Maternal mortality in the Far Eastern Federal District during the pre-epidemic period and three years of the Covid-19 pandemic

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective: This study aimed to evaluate the structure and indicators of maternal mortality (MM) in the Far Eastern Federal District (FEFD) during the pre-epidemic period and the first three years of the novel coronavirus infection (NCI) pandemic.

Materials and methods: A retrospective comparative analysis of the dynamics of the MM indicators and structure in FEFD for the years 2019–2022 was conducted. A statistical database was generated from the emergency notification cards of the MM cases. In all cases of maternal loss from COVID-19, SARS-CoV-2 was identified by PCR in the nasopharyngeal material.

Results: The dynamics of the MM rate in FEFD during the reported period showed trends similar to those of the all-Russian rate. However, the MM rate exceeded the all-Russian rate by 18.9‰ (RF 9.8‰) in 2019, by 22.4‰ (RF 16.3‰) in 2020, by 45.3‰ (RF 42.4‰) in 2021, and by 23.2‰ (RF 12.6‰) in 2022. In the pre-epidemic year 2019, obstetric causes accounted for the largest proportion (82.4%), whereas the proportion of extragenital diseases (EGD) was significantly lower at 17.6% (χ2=11.8; p<0.001). In the first year of the COVID-19 pandemic (2020), MM increased owing to a significant increase in EGD mortality from 17.6% in 2019 to 75.0% (χ2=9.9; p=0.002), of which NCI accounted for a large proportion (40.0%). Maternal mortality from non-communicable diseases increased 2.0-fold: 17.6% (2019) vs. 35.0% (2020), indicating organizational challenges in the care of patients with EGD. The proportion of obstetric causes of MM decreased from 82.4% to 25.0% (χ2=9.9, p=0.002). In the second year of the epidemic, there was a 2.0-fold increase in MM due to a multiple of COVID-19 maternal losses: 66.6% (2021) vs. 40.0% (2020) (χ2=3.9; p=0.050), driven by the greater pathogenicity of the delta strain. The proportion of obstetric causes of MM did not change significantly: 20.5% (2021) vs. 25.0% (2020), p=0.951, but there was a 1.5-fold increase in the number of female villagers (43.6% vs. 30%). In the third year of the pandemic, EGDs remained the leading cause of MM, with no significant change in their proportion: 68.4% (2022) vs. 66.6% (2021), p=0.870. Notably, there was a significant decrease in the proportion of MM cases from the NCI (15.7 % (2022) vs. 66.6 % (2021), p<0.001), while there was a significant increase in the number of losses from severe non-infectious EGD. None of these pregnant and postpartum women had been examined by a specialist prior to pregnancy and had received no pre-pregnancy care. There was late seeking of medical attention and, in some cases, underestimation of severity and clinical symptoms in primary health care settings and by allied specialists.

Conclusion: The dynamics and structure of MM in FEFD, as revealed in this study, underscore the need for management decisions aimed at improving the current system of medical examination of fertile-age patients and routing of pregnant women who are at risk of developing critical obstetric conditions.

Full Text

Restricted Access

About the authors

Tatiana E. Belokrinitskaya

Chita State Medical Academy, Ministry of Health of Russia

Author for correspondence.
Email: tanbell24@mail.ru
ORCID iD: 0000-0002-5447-4223

Dr. Med. Sci., Professor, Head of the Obstetrics and Gynecology Department of the Pediatric Faculty and Faculty of Professional Retraining

Russian Federation, 672000, Russia, Chita, Gorky str., 39a

Roman G. Shmakov

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: r_shmakov@oparina4.ru
ORCID iD: 0000-0002-2206-1002

Dr. Med. Sci., Professor of the RAS, Head of the Institute of Obstetrics

Russian Federation, 117997, Moscow, Oparin str., 4

Nataly I. Frolova

Chita State Medical Academy, Ministry of Health of Russia

Email: tanbell24@mail.ru
ORCID iD: 0000-0002-7433-6012

Dr. Med. Sci., Associate Professor at the Department of Obstetrics and Gynecology of the Pediatric Faculty and Faculty of Professional Retraining

Russian Federation, 672000, Chita, Gorky str., 39a

Olga Yu. Brum

Transbaikal Regional Perinatal Centre, Ministry of Health of Russia

Email: ymnenkaya@yandex.ru
ORCID iD: 0000-0002-6065-3666

Deputy Chief Physician for Obstetrics and Gynecological Care

Russian Federation, 672090, Chita, Kokhansky str., 16

Natalia A. Krivoshchekova

Blagoveshchenskaya City Clinical Hospital, Ministry of Health of Russia

Email: zamrod_gkb1@mail.ru
ORCID iD: 0000-0001-9345-1553

Deputy Chief Physician for Obstetrics and Gynecology

Russian Federation, 675000, Amur region, Blagoveshchensk, Gorky str., 247

Tatiana Yu. Pavlova

Perinatal Center of the Republic of Sakha (Yakutia) "Republican Hospital No. 1 of the National Center of Medicine"

Email: tatyanaupavl@mail.ru
ORCID iD: 0000-0002-3319-912X

PhD, Director, Perinatal Center of the Republic of Sakha (Yakutia) Republican Hospital No. 1 of the National Center of Medicine

Russian Federation, 677010, Republic of Sakha (Yakutia), Yakutsk, Sergelyakhskoe highway, 4

Marina P. Rinchindorzhiyeva

Buryat Republic Perinatal Center

Email: marirmp@mail.ru
ORCID iD: 0000-0003-1153-6057

PhD, Head of the Organizational and Methodological Unit

Russian Federation, 670047, Ulan-Ude, Pirogova str., 15B

References

  1. WHO. A woman dies every two minutes due to pregnancy or childbirth: UN agencies. 23 February 2023. https://www.who.int/ru/news/item/ 23-02-2023-a-woman-dies-every-two-minutes-due-to-pregnancy-or-childbirth --un-agencies
  2. RCOG. Restoration and Recovery: Priorities for obstetrics and gynaecology. A prioritization framework for care in response to COVID-19. Version 2.1. Published Friday 26 June 2020. 27 р.
  3. Chen H., Guo J., Wang C., Luo F., Yu X., Zhang W. еt al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020; 395(10226):809-15. https://doi.org/ 10.1016/S0140-6736(20)30360-3.
  4. Белокриницкая Т.Е., Артымук Н.В., Филиппов О.С., Фролова Н.И. COVID-19 у беременных Сибири и Дальнего Востока: итоги 2 лет пандемии. Акушерство и гинекология. 2022; 4: 47-54. [Belokrinitskaya T.E., Artymuk N.V., Filippov O.S., Frolova N.I. COVID-19 in pregnant women of Siberia and the Russian Far East: 2-year results of the pandemic. Obstetrics and Gynecology. 2022; (4): 47-54 (in Russian)]. https://dx.doi.org/10.18565/aig.2022.4.47-54.
  5. Faria N.R., Mellan T.A., Whittaker C., Claro I.M., Candido D.S., Mishra S. еt al. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science. 2021; 372(6544):815-21. https://dx.doi.org/10.1016/10.1126/science.abh2644.
  6. Andeweg S.P., Vennema H., Veldhuijzen I., Smorenburg N., Schmitz D., Zwagemaker F. еt al.; SeqNeth Molecular surveillance group and RIVM COVID-19 Molecular epidemiology group. Elevated risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variants compared with Alpha variant in vaccinated individuals. Sci. Transl. Med. 2023;15(684):eabn4338. https://dx.doi.org/10.1016/10.1126/scitranslmed.abn4338.
  7. Dyer O. Covid-19: Omicron is causing more infections but fewer hospital admissions than delta, South African data show. BMJ. 2021; 375:n3104. https://dx.doi.org/10.1016/doi: 10.1136/bmj.n3104.
  8. Sharif N., Alzahrani K.J., Ahmed S.N., Khan A., Banjer H.J., Alzahrani F.M. et al. Genomic surveillance, evolution and global transmission of SARS-CoV-2 during 2019–2022. PLoS One. 2022; 17(8): e0271074. https://doi.org/10.1371/journal.pone.0271074.
  9. Министерство здравоохранения Российской Федерации. Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». Версия 17 (14.12.2022). [Ministry of Health of the Russian Federation. Temporary methodological guidelines “Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)”. Version 17 (14.12.2022). (in Russian)].
  10. Chmielewska B., Barratt I., Townsend R., Kalafat E., van der Meulen J., Gurol-Urganci I. et al. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. Lancet Glob. Health. 2021; 9(6):e759-e772. https://dx.doi.org/10.1016/10.1016/ S2214-109X(21)00079-6.
  11. Litman E.A., Yin Y., Nelson S.J., Capbarat E., Kerchner D., Ahmadzia H.K. et al. Adverse perinatal outcomes in a large United States birth cohort during the COVID-19 pandemic. Am. J. Obstet. Gynecol. MFM. 2022;4(3):100577. https://dx.doi.org/10.1016/10.1016/ j.ajogmf.2022.100577.
  12. Указ Президента Российской Федерации от 03.11.2018 № 632 «О внесении изменений в перечень федеральных округов», утвержденный Указом Президента Российской Федерации от 13 мая 2000 г. № 849. Режим доступа: http://publication.pravo.gov.ru/Document/View/0001201811040002/ [Decree of the President of the Russian Federation of 03.11.2018 No. 632 "On amendments to the list of Federal districts" approved by Decree of the President of the Russian Federation of May 13, 2000 No 849. Available at: http://publication.pravo.gov.ru/Document/View/0001201811040002/(in Russian)].
  13. Министерство здравоохранения Российской Федерации. Организация оказания медицинской помощи беременным, роженицам, родильницам и новорожденным при новой коронавирусной инфекции COVID-19. Методические рекомендации. Версия 5 (28.12.2021). [Ministry of Health of the Russian Federation. Organization of medical care for pregnant women, women in labor, women in labor and newborns with a new coronavirus infection COVID-19. Methodological guidelines. Version 5 ( 28.12.2021). (in Russian)].
  14. Mihajlovic S., Nikolic D., Santric-Milicevic M., Milicic B., Rovcanin M., Acimovic A., Lackovic M. Four Waves of the COVID-19 Pandemic: сomparison of Clinical and Pregnancy Outcomes. Viruses 2022; 14(12): 2648. https://dx.doi.org/10.1016/10.3390/v14122648.
  15. Del Rio C., Malani P.N., Omer S.B. Confronting the Delta variant of SARS-CoV-2, summer 2021. JAMA. 2021; 326(11):1001-2. https://dx.doi.org/10.1016/10.1001/jama.2021.14811.
  16. Vousden N., Ramakrishnan R., Bunch K., Morris E., Simpson N., Gale C. et al. Management and implications of severe COVID-19 in pregnancy in the UK: data from the UK Obstetric Surveillance System national cohort. Acta Obstet. Gynecol. Scand. 2022;101(4):461-70. https://dx.doi.org/10.1016/ 10.1111/aogs.14329.
  17. Белокриницкая Т.Е., Фролова Н.И., Колмакова К.А., Шаметова Е.А. Факторы риска и особенности течения COVID-19 у беременных: сравнительный анализ эпидемических вспышек 2020 и 2021 г. Гинекология. 2021; 23 (5): 421-7. [Belokrinitskaya T.E., Frolova N.I., Kolmakova K.A., Shametova E.A. Risk factors and features of COVID-19 course in pregnant women: a comparative analysis of epidemic outbreaks in 2020 and 2021. Gynecology. 2021; 23 (5): 421-7 (in Russian)]. https://dx.doi.org/10.1016/ 10.26442/20795696.2021.5.201107.
  18. Артымук Н.В., Белокриницкая Т.Е., Парфенова Я.А., Фролова Н.И. Мониторинг вакцинации беременных против COVID-19 в Сибирском и Дальневосточном федеральных округах. Акушерство и гинекология. 2022; 5: 53-8. [Artymuk N.V., Belokrinitskaya T.E., Parfenova Ya.A., Frolova N.I. Monitoring of COVID-19 vaccination in pregnant women of Siberia and the Russian Far East. Obstetrics and Gynecology. 2022; (5): 53-8 (in Russian)]. https://dx.doi.org/10.18565/aig.2022.5.53-58.
  19. Белокриницкая Т.Е., Артымук Н.В., Филиппов О.С., Фролова Н.И., Парфенова Я.А. Материнская смертность и near miss при новой коронавирусной инфекции (COVID-19) у беременных Сибири и Дальнего Востока. Проблемы репродукции. 2021; 27(5): 114-20. [Belokrinitskaya T.E., Artymuk N.V., Filippov O.S., Frolova N.I., Parfenova Ya.A. Maternal mortality and critical conditions (near miss) in COVID-19 in pregnant women of Siberia and the Far East. Russian Journal of Human Reproduction. 2021;27(5):114-20. (in Russian)]. https://dx.doi.org/10.1016/10.17116/repro202127051114.
  20. Антонова М.И., Колмакова К.А., Румянцева К.А., Шаметова Е.А., Белокриницкая Т.Е., Фролова Н.И. Факторы риска и особенности течения СOVID-19 у беременных в динамике эпидемического процесса. Медицина завтрашнего дня. Материалы XXI межрегиональной научно-практической конференции студентов и молодых ученых с международным участием. Чита; 2022: 94-5. [Antonova M.I., Kolmakova K.A., Rumyantseva K.A., Shametova E.A., Belokrinitskaya T.E., Frolova N.I. Risk factors and features of the course of COVID-19 in pregnant women in the dynamics of the epidemic process. In: Medicine of Tomorrow. Materials of the XXI interregional scientific and practical conference of students and young scientists with international participation. Chita; 2022: 94-5 (in Russian)].

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig.1.

Download (58KB)
3. Fig.2.

Download (72KB)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies